The Parkinson-Control Study: A 1-year randomized, double-blind trial comparing piribedil (150 mg/ day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson’s disease - Castro-Caldas, A; Delwaide, P; Jost, W (Mov Disord, 2006)
et al.